Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001819790-25-000108
Filing Date
2025-08-06
Accepted
2025-08-06 16:10:16
Documents
83
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tars-20250630.htm   iXBRL 10-Q 1790316
2 EX-10.1 amendmentdatedmay12025to.htm EX-10.1 7159
3 EX-31.1 exhibit311-63025.htm EX-31.1 9701
4 EX-31.2 exhibit312-63025.htm EX-31.2 10074
5 EX-32.1 exhibit321-63025.htm EX-32.1 6101
6 EX-32.2 exhibit322-63025.htm EX-32.2 5974
12 amendmentdatedmay12025to001.jpg GRAPHIC 257360
13 amendmentdatedmay12025to002.jpg GRAPHIC 98125
14 amendmentdatedmay12025to003.jpg GRAPHIC 56367
15 amendmentdatedmay12025to004.jpg GRAPHIC 49873
  Complete submission text file 0001819790-25-000108.txt   8966010

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tars-20250630.xsd EX-101.SCH 50559
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tars-20250630_cal.xml EX-101.CAL 81947
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tars-20250630_def.xml EX-101.DEF 223058
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tars-20250630_lab.xml EX-101.LAB 693084
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tars-20250630_pre.xml EX-101.PRE 482139
86 EXTRACTED XBRL INSTANCE DOCUMENT tars-20250630_htm.xml XML 1148631
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39614 | Film No.: 251189636
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)